BEGHINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 4.833
NA - Nord America 4.678
AS - Asia 3.106
SA - Sud America 369
AF - Africa 123
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.135
Nazione #
US - Stati Uniti d'America 4.563
GB - Regno Unito 2.016
CN - Cina 1.090
SG - Singapore 886
IT - Italia 711
SE - Svezia 449
DE - Germania 421
RU - Federazione Russa 368
BR - Brasile 297
HK - Hong Kong 247
IN - India 212
FR - Francia 137
NL - Olanda 137
TR - Turchia 135
KR - Corea 122
UA - Ucraina 113
IE - Irlanda 104
JP - Giappone 95
FI - Finlandia 94
VN - Vietnam 94
ID - Indonesia 83
CA - Canada 79
DK - Danimarca 62
EU - Europa 58
CI - Costa d'Avorio 47
ES - Italia 34
GR - Grecia 34
TN - Tunisia 34
AR - Argentina 24
PL - Polonia 23
CH - Svizzera 21
BD - Bangladesh 20
MX - Messico 20
BE - Belgio 19
CO - Colombia 18
ZA - Sudafrica 17
CZ - Repubblica Ceca 16
AU - Australia 15
NO - Norvegia 15
AT - Austria 14
RO - Romania 14
IR - Iran 10
PK - Pakistan 10
SA - Arabia Saudita 9
UZ - Uzbekistan 9
IQ - Iraq 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
EC - Ecuador 6
IL - Israele 6
PH - Filippine 6
PT - Portogallo 6
TW - Taiwan 6
JM - Giamaica 5
KG - Kirghizistan 5
MA - Marocco 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
RS - Serbia 5
BY - Bielorussia 4
CL - Cile 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
QA - Qatar 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
AL - Albania 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
TH - Thailandia 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
Totale 13.178
Città #
Southend 1.872
Ashburn 537
Boise 537
Singapore 523
Milan 321
Chandler 286
Seattle 238
Beijing 218
Fairfield 217
Hong Kong 212
Wilmington 167
Princeton 139
Woodbridge 137
Dearborn 123
Frankfurt am Main 115
Council Bluffs 113
Ann Arbor 110
Dublin 104
Houston 104
Dallas 93
Cambridge 90
Hefei 83
Nanjing 82
Bengaluru 75
Redmond 75
Mountain View 70
Redwood City 68
Jakarta 66
Jacksonville 65
Los Angeles 63
Buffalo 59
New York 55
Santa Clara 55
Des Moines 49
Sakarya 48
Abidjan 47
Guangzhou 46
Boardman 43
Tokyo 41
Moscow 38
Shanghai 38
Phoenix 37
Saint Petersburg 36
Athens 33
Columbus 32
Garden Valley 32
São Paulo 32
Seoul 31
Toronto 30
Ho Chi Minh City 28
Jerome 27
Tianjin 27
Andover 26
Payette 26
Berlin 25
Hangzhou 25
Tunis 25
Munich 24
Cangzhou 23
Lewiston 23
Hanoi 22
Hanover 22
The Dalles 22
Cottonwood 19
Eitensheim 19
Serra 19
Turku 19
Concorezzo 18
Hebei 18
Helsinki 18
Shenyang 18
Bogotá 17
Changsha 17
Jinan 17
Nanchang 17
San Diego 17
Brussels 15
Chicago 15
Brugherio 14
Bühl 14
Grafing 14
Kent 14
Melegnano 14
Rio de Janeiro 14
Roxbury 14
London 13
Orofino 13
Shenzhen 13
Fino Mornasco 12
Rome 12
Silver Spring 12
Wuhan 12
Zhengzhou 12
Chengdu 11
Fuzhou 11
Jiaxing 11
Chennai 10
Florence 10
Halifax 10
Hyderabad 10
Totale 8.563
Nome #
STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade 742
KIT activating mutations : incidence in adult and pediatric AML, and identification of an internal tandem duplication 633
Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis 467
FZD6 triggers Wnt-signalling driven by WNT10BIVS1 expression and highlights new targets in T cell acute lymphoblastic leukemia 340
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index 312
Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta. 303
FZD6 (Frizzled class receptor 6) 286
An unusual mutation in RECQ4 gene leading to Rothmund-Thomson syndrome 280
FZD4 (frizzled class receptor 4) 271
Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. 265
Identification of kitM541l somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response 258
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia (Scientific Reports (2017) 6 (37201) DOI: 10.1038/srep37201) 253
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia 235
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations - A report of three cases 234
Core Binding Factor Leukemia : Chromatin Remodeling Moves Towards Oncogenic Transcription 226
WNT10B (Wingless-Type MMTV Integration Site Family) 224
Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits 222
PTPN6 (protein tyrosine phosphatase, non-receptor type 6) 212
Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses. [Erratum to document cited in CA144:085286] 206
The Kasumi-1 cell line : a t(8;21)-kit mutant model for acute myeloid leukemia 206
Targeting WNT10B-Driven Signalling through Induction of FZD6 By Porcupine Inhibition in T Cell Acute Lymphoblastic Leukemia 205
Regeneration-associated Wnt signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells 197
A novel start‐loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms 197
A stability-based algorithm to validate hierarchical clusters of genes 183
The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines 183
Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement 181
An algorithm to assess the reliability of hierarchical clusters in gene expression data 181
Prognostic impact of c-KIT mutations in core binding factor leukemias. an Italian retrospective study 180
Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia 171
Distinct expression pattern of microtubule-associated protein/microtubule affinity-regulating kinase 4 in differentiated neurons 168
Molecular screening of PDGFRA and PDGFRB genes in KIT and FLT3 negative core binding factor leukemias 163
Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence 162
Familial / sporadic gastrointestinal stromal tumors (GISTs) 161
A mathematical model for the validation of gene selection methods 160
Clinical relevance of recurrent allele-specific recombination expressing the WNT10Bivs1 allele variant in acute myeloid leukemia 160
Rothmund-Thomson syndrome (RTS) 156
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia 154
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells 151
Identification of two novel RECQL4exonic SNPs and genomic characterization of the IVS12 minisatellite 150
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) 150
Molecular events in acute myeloid leukemogenesis: a model from core binding factor leukemia 144
PTPN13 (Protein tyrosine phosphatase, nonreceptor type 13) 144
Prevalence and prognostic impact of KIT mutations in acute myeloid leukaemia with inv(16). A retrospective study 144
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorfism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation 142
Prognostic impact of C-KIT mutations in Core Binding Factor-Leukemia 136
IMPACT OF KIT MUTATIONS IN ACUTE MYELOID LEUKAEMIA WITH INV(16) 135
c-kit activating mutations and mast cell proliferation in human leukemia 133
RNA processing defects of the helicase gene RECQL4 in a compound heterozygous Rothmund-Thomson patient 132
+4 or trisomy 4 132
Germline mutation in the juxtamembrane domain of KIT gene in a family with GISTs and Urticaria Pigmentosa 130
Serum tryptase levels in AML at diagnosis : a multicenter retrospective study 128
Total serum tryptase : a predictive marker for KIT mutation in acute myeloid leukemia 122
C-kit mutations in core binding factor leukemias 122
KIT mutations in core binding factor leukemias: outcome prediction and therapeutic implications 121
MARK4 (MAP/microtubule affinity-regulating kinase 4) 121
Systemic mast cell disease 117
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 116
Piebaldism 115
AML with t(8;21) and trisomy 4: possible involvement of c-kit? 114
RECQL4 (RecQ protein-like 4) 105
Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified 104
High frequency of c-kit mutation in core binding factor leukemia 102
Prognostic markers in AML : focus on CBFL 101
KITLG (KIT ligand) 98
KITLG (KIT ligand) 98
Carbonic Anhydrase 9: mastering ferropoptosis resistance in cancer, protector or weak point? 92
Common Gene Expression Signature of B-Cells of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathies of Undetermined Significance (IgM MGUS) Compared to Healthy Subjects 90
Primary hypereosinophilic sindromes and imatinib therapy: a rtrospective analysis of 38 cases 90
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation 85
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 74
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation 73
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects 72
Efficacy of Midostaurin Combined with Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial 68
Genetic Landscape and Clonal Evolution Patterns of CEBPA-Mutated Acute Myeloid Leukaemia Based on NextGeneration Sequencing: A Retrospective Analysis 68
CSNK2A2 (casein kinase 2 alpha 2) 65
Beyond the Warburg Effect: KRAS/MAPK-Driven Uridine Utilization in Glucose-Deprived Pancreatic Ductal Adenocarcinoma 63
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 59
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 57
Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results 56
Bloom syndrome 28
null 3
Totale 13.687
Categoria #
all - tutte 33.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021962 0 0 0 0 0 73 60 69 284 106 265 105
2021/20221.086 110 87 52 84 111 58 96 72 83 87 81 165
2022/20231.207 143 140 98 138 139 202 31 104 106 22 45 39
2023/2024993 22 51 51 41 185 51 55 276 22 48 81 110
2024/20252.058 75 196 50 204 152 118 101 221 103 158 184 496
2025/20261.918 348 295 372 424 429 50 0 0 0 0 0 0
Totale 13.687